Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 6

Therapeutics and Clinical Risk Management


Archive: Volume 4, 2008


Erratum

Rapidis A, Sarlis N, Lefebvre J-L, et al

Therapeutics and Clinical Risk Management 2008, 4:1381-1381

Published Date: 5 December 2008

A thyrotoxicosis outbreak due to dietary pills in Paris

Vincent Ioos, Vincent Das, Eric Maury, Jean-Luc Baudel, Jérôme Guéchot, et al

Therapeutics and Clinical Risk Management 2008, 4:1375-1379

Published Date: 5 December 2008

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

Dimitrios Chantzichristos, Andréasson Björn, Johansson Peter

Therapeutics and Clinical Risk Management 2008, 4:1371-1374

Published Date: 5 December 2008

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

Thérèse H Franco, Ahmed Khan, Vishal Joshi, Beje Thomas

Therapeutics and Clinical Risk Management 2008, 4:1367-1370

Published Date: 5 December 2008

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

Tamana Walia, J Fernando Quevedo, Timothy J Hobday, Gary Croghan, Aminah Jatoi

Therapeutics and Clinical Risk Management 2008, 4:1363-1366

Published Date: 5 December 2008

Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer

Kyriaki Pistevou-Gompaki, Apostolos Hatzitolios, Nikos Eleftheriadis, Evaggelos Boultoukas, George Ntaios, et al

Therapeutics and Clinical Risk Management 2008, 4:1359-1362

Published Date: 5 December 2008

Effects of treatment with antimicrobial agents on the human colonic microflora

Fatemeh Rafii, John B Sutherland, Carl E Cerniglia

Therapeutics and Clinical Risk Management 2008, 4:1343-1357

Published Date: 5 December 2008

Newer treatments for fibromyalgia syndrome

Richard E Harris, Daniel J Clauw

Therapeutics and Clinical Risk Management 2008, 4:1331-1342

Published Date: 5 December 2008

Tadalafil in the treatment of erectile dysfunction

Robert M Coward, Culley C Carson

Therapeutics and Clinical Risk Management 2008, 4:1315-1329

Published Date: 5 December 2008

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-Centeno

Therapeutics and Clinical Risk Management 2008, 4:1305-1313

Published Date: 5 December 2008

Exemestane in early breast cancer: a review

Michael Untch, Christian Jackisch

Therapeutics and Clinical Risk Management 2008, 4:1295-1304

Published Date: 5 December 2008

Vinflunine in the treatment of bladder cancer

Mark Bachner, Maria De Santis

Therapeutics and Clinical Risk Management 2008, 4:1243-1253

Published Date: 5 December 2008

Bazedoxifene for the prevention of postmenopausal osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Giuseppe Martini, Ranuccio Nuti

Therapeutics and Clinical Risk Management 2008, 4:1229-1242

Published Date: 5 December 2008

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Daanish Hoda, George R Simon, Christopher R Garrett

Therapeutics and Clinical Risk Management 2008, 4:1221-1227

Published Date: 5 December 2008

Febuxostat in the management of hyperuricemia and chronic gout: a review

Miao Hu, Brian Tomlinson

Therapeutics and Clinical Risk Management 2008, 4:1209-1220

Published Date: 5 December 2008

Mometasone furoate in the management of asthma: a review

Ricardo A Tan, Jonathan Corren

Therapeutics and Clinical Risk Management 2008, 4:1201-1208

Published Date: 5 December 2008

Impact of PPIs on patient focused symptomatology in GERD

ABR Thomson

Therapeutics and Clinical Risk Management 2008, 4:1185-1200

Published Date: 5 December 2008

Treatment of severe psoriasis with infliximab

JA Leman, AD Burden

Therapeutics and Clinical Risk Management 2008, 4:1165-1175

Published Date: 5 December 2008

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Vinay Gudena, Alberto J Montero, Stefan Glück

Therapeutics and Clinical Risk Management 2008, 4:1157-1164

Published Date: 5 December 2008

Tolvaptan and its potential in the treatment of hyponatremia

Megan B Dixon, Y Howard Lien

Therapeutics and Clinical Risk Management 2008, 4:1149-1155

Published Date: 5 December 2008